The impact of chronic kidney disease and short-term treatment with rosiglitazone on plasma cell-free DNA levels
© 2014 Amanda L. McGuire et al. Patients with chronic kidney disease (CKD) are at increased risk of cardiovascular disease. Circulating free nucleic acids, known as cell-free DNA (cfDNA), have been proposed as a novel biomarker of cardiovascular risk. The impact of renal impairment on cfDNA levels a...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
Hindawi Publishing Corporation
2014
|
| Online Access: | http://hdl.handle.net/20.500.11937/36790 |